Analisis Keuangan Saham DTC - Defence Therapeutics Inc. (CNSX) Stock

Gambaran Umum

Defence Therapeutics Inc. is a Canadian biotechnology company primarily focused on the development of innovative treatments in the field of cancer therapy and infectious diseases. The company is leveraging its proprietary AccumTM technology platform, which enhances the delivery and efficacy of existing immunotherapies and vaccines. Notably, their research and development efforts are concentrated on ADC (Antibody-Drug Conjugates) technology, a pivotal area in targeted cancer treatments. Defence Therapeutics is actively engaged in advancing a pipeline of therapeutic candidates that aim to improve the precision and outcomes of cancer treatment, demonstrating a robust commitment to addressing significant unmet medical needs in the oncology sector.

Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih

Nilai operating income untuk Defence Therapeutics Inc. per 2025 Mar 31 adalah -4.52 MM.
Nilai net income untuk Defence Therapeutics Inc. per 2025 Mar 31 adalah -3.71 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-03-31		-4.52	-3.71
2024-12-31		-4.72	-4.09
2024-09-30		-11.12	-11.60
2024-06-30		-12.75	-13.19
2024-03-31		-11.72	-13.57
2023-12-31		-11.98	-13.59
2023-09-30		-6.95	-7.26
2023-06-30		-6.49	-6.76
2023-03-31		-6.94	-7.21
2022-12-31		-7.38	-7.56
2022-09-30		-7.40	-7.52
2022-06-30		-7.27	-7.34
2022-03-31		-6.78	-6.85
2021-12-31		-5.78	-5.85
2021-09-30		-4.31	-4.35
2021-06-30		-2.83	-2.86
2021-03-31		-1.63	-1.65
2020-12-31		-1.15	-1.15
2020-09-30		-0.71	-0.71
2020-06-30

Laporan Laba Rugi: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-03-31
2024-12-31	-0.09	-0.09
2024-09-30	-0.26	-0.26
2024-06-30	-0.30
2024-03-31	-0.31	-0.31
2023-12-31	-0.32	-0.32
2023-09-30	-0.18	-0.18
2023-06-30	-0.17
2023-03-31	-0.19	-0.19
2022-12-31	-0.21	-0.21
2022-09-30	-0.21	-0.21
2022-06-30	-0.20
2022-03-31	-0.20	-0.20
2021-12-31	-0.18	-0.18
2021-09-30	-0.14	-0.14
2021-06-30	-0.11
2021-03-31	-0.09	-0.09
2020-12-31	-0.04	-0.04
2020-09-30	-0.03	-0.03
2020-06-30	-0.71

Arus Kas: Operasi, Investasi, Pendanaan

Nilai cash from operating activities untuk Defence Therapeutics Inc. per 2025 Mar 31 adalah -3.11 MM.
Nilai cash from investing activities untuk Defence Therapeutics Inc. per 2025 Mar 31 adalah 0.04 MM.
Nilai kas dari aktivitas pendanaan untuk Defence Therapeutics Inc. per 2025 Mar 31 adalah 4.64 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-03-31	-3.11	0.04	4.64
2024-12-31	-2.05	-0.18	2.01
2024-09-30	-2.78	-0.20	1.76
2024-06-30	-4.29	-0.20	1.76
2024-03-31	-5.90	-0.23	3.77
2023-12-31	-6.77	-0.01	6.97
2023-09-30	-7.55	-0.07	8.84
2023-06-30	-7.66	-0.07	10.01
2023-03-31	-6.78	-0.06	8.13
2022-12-31	-6.52	-0.06	3.89
2022-09-30	-6.07		1.69
2022-06-30	-6.04		1.10
2022-03-31	-6.07		1.02
2021-12-31	-5.04		0.81
2021-09-30	-3.72		5.84
2021-06-30	-2.29		5.88
2021-03-31	-1.13	-0.05	7.81
2020-12-31	-0.60	-0.05	7.73
2020-09-30	-0.20	-0.05	2.64
2020-06-30

Metrik Penilaian: PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30

Metrik Penilaian: EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30

Efektivitas Manajemen

roa untuk Defence Therapeutics Inc. pada 2025 Mar 31 adalah -4.22.

Period End (TTM)	ROA	ROE	ROIC (Tingkat Pengembalian Investasi Modal)	CROIC	OCROIC
2025-03-31	-4.22
2024-12-31	-17.35
2024-09-30	-8.31
2024-06-30	-4.31	-10.20
2024-03-31	-30.43		-15.86	0.22	-7.90
2023-12-31	-24.13		-6.07	1.02	-6.31
2023-09-30	-10.02		-2.11	0.71	-2.39
2023-06-30	-10.51		-2.06	0.70
2023-03-31	-4.14	-4.76	-2.36	0.42
2022-12-31	-1.54	-1.65
2022-09-30	-1.41	-1.65
2022-06-30	-1.22	-1.34
2022-03-31	-0.87	-1.04	-4.52	-3.34	-4.01
2021-12-31	-0.61	-0.82	-2.00	-1.45	-0.82
2021-09-30	-1.76	-1.80	-0.96	0.47	-0.17
2021-06-30	-1.50	-1.53	-0.52	0.65	-0.42
2021-03-31			-0.25	1.01	-0.17
2020-12-31	-147.78		-0.16	1.00	-0.09
2020-09-30	-91.20		-0.29	0.99	-0.08
2020-06-30	-86.69		-0.36	1.00	-0.07

Gross Margins

Margin Kotor: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Margin Keuntungan Bersih: Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.

Margin Operasi: Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.

Period End (TTM)	Margin Kotor	Margin Keuntungan Bersih	Margin Operasi
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30